The major challenge in prostate cancer screening is not just to find more cancer cases, but to identify the cancers that are ...

New research among lung cancer screening participants has found that low-dose chest computed tomography (CT) screening is ...

Share on Pinterest A first-of-its-kind AI tool was cleared by the FDA to detect underlying structural heart disease before symptoms present. ljubaphoto/Getty Images The FDA cleared the first ...

Current regulatory frameworks for artificial intelligence-based clinical decision support (AICDS) are insufficient to ensure safety, effectiveness, and equity at the bedside. The oversight of clinical ...

Daniel W. Lin, MD, reviews new guidance on using MRI, biomarkers, and more, to improve the detection of prostate cancer.

New imaging tools, exercise testing, and phenotype-based therapy are reshaping how clinicians diagnose and treat HFpEF.